Impact of Low-intensity Chemotherapy Combined With Short-course Blinatumomab on Allo-HSCT in Adults With Ph- B-ALL

Clinical trial NCT06930105 · NOT_YET_RECRUITING

Trial details

NCT number

NCT06930105

Sponsor

Xianmin Song, MD

Status

NOT_YET_RECRUITING

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2025-09-01

Primary completion

2027-11-01

Enrollment

45

View on ClinicalTrials.gov